Detalhe da pesquisa
1.
Mycophenolate Mofetil for First-Line Treatment of Immune Thrombocytopenia.
N Engl J Med
; 385(10): 885-895, 2021 09 02.
Artigo
Inglês
| MEDLINE | ID: mdl-34469646
2.
CD4+ T cells from patients with glucocorticoid-refractory immune thrombocytopenia have altered cytokine expression.
Br J Haematol
; 196(4): 1113-1117, 2022 02.
Artigo
Inglês
| MEDLINE | ID: mdl-34632576
3.
Factors Predicting Long-term Outcome and the Need for Surgery in Graves Orbitopathy: Extended Follow-up From the CIRTED Trial.
J Clin Endocrinol Metab
; 108(10): 2615-2625, 2023 09 18.
Artigo
Inglês
| MEDLINE | ID: mdl-36971324
4.
Letter on Predicting the number of sites needed to deliver a multicentre clinical trial within a limited time frame in the UK.
Trials
; 21(1): 873, 2020 Oct 21.
Artigo
Inglês
| MEDLINE | ID: mdl-33087161
5.
Prostaglandin F2-Alpha Eye Drops (Bimatoprost) in Graves' Orbitopathy: A Randomized Controlled Double-Masked Crossover Trial (BIMA Trial).
Thyroid
; 29(4): 563-572, 2019 04.
Artigo
Inglês
| MEDLINE | ID: mdl-30880626
6.
Trial protocol: a multicentre randomised trial of first-line treatment pathways for newly diagnosed immune thrombocytopenia: standard steroid treatment versus combined steroid and mycophenolate. The FLIGHT trial.
BMJ Open
; 8(10): e024427, 2018 10 18.
Artigo
Inglês
| MEDLINE | ID: mdl-30341143
7.
Combined immunosuppression and radiotherapy in thyroid eye disease (CIRTED): a multicentre, 2â×â2 factorial, double-blind, randomised controlled trial.
Lancet Diabetes Endocrinol
; 6(4): 299-309, 2018 04.
Artigo
Inglês
| MEDLINE | ID: mdl-29396245